<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Tissue factor (TF) is a significant risk factor for <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastasis</z:e> in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to investigate whether <z:hpo ids='HP_0001945'>hyperthermia</z:hpo> has synergistic anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> effects with TF knockdown in suppressing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in vitro and in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> LOVO cells were treated by <z:hpo ids='HP_0001945'>hyperthermia</z:hpo> at 44Â°C for 2 hr or/and TF siRNA </plain></SENT>
<SENT sid="3" pm="."><plain>Then the cells were subjected to colony formation assay </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was analyzed by flow cytometry, confocal microscopy, and transmission electron microscopy </plain></SENT>
<SENT sid="5" pm="."><plain>The cell migration and invasion abilities were analyzed by wound healing and matrigel assay </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, orthotopic <z:mp ids='MP_0003815'>nude</z:mp> mice model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was established </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0001945'>Hyperthermia</z:hpo> synergized with TF knockdown to reduce colony formation ability, induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and suppress the migration and invasion of LOVO cells in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, <z:hpo ids='HP_0001945'>hyperthermia</z:hpo> in combination with TF <z:mpath ids='MPATH_63'>depletion</z:mpath> inhibited the growth and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in orthotopic <z:mp ids='MP_0003815'>nude</z:mp> mice model </plain></SENT>
<SENT sid="9" pm="."><plain>Mechanistically, the synergistic effects were at least partly mediated by inducing JNK mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and suppressing matrix metalloproteinases (MMPs) mediated invasion </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0001945'>Hyperthermia</z:hpo> in combination with TF-targeted therapy could be a potential approach for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> treatment </plain></SENT>
</text></document>